| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/1990 | US4945086 Smooth muscle cell growth inhibitor |
| 07/31/1990 | US4945082 Measuring immune deficit, stabilizing with mismatched double-stranded rna |
| 07/31/1990 | US4945055 Human chorionic gonadotropin releasing factor |
| 07/31/1990 | US4945054 Process for the separation and purification of proteases and antiproteases of blood clotting, as well as of the protease/antiprotease complex |
| 07/31/1990 | US4945051 Production of human lysozyme |
| 07/31/1990 | US4944948 EGF/Liposome gel composition and method |
| 07/31/1990 | US4944944 For increasing fat absorption and animal growth; infant formulas |
| 07/31/1990 | US4944943 Mixture of a substance having thrombolytic activity and of an antithrombotic substance |
| 07/31/1990 | US4944941 Surfactants |
| 07/31/1990 | CA2006964A1 Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full cdna thereof |
| 07/31/1990 | CA1272131A1 Methods for preparation of highly purified, gamma globulins free of hepatitis-b-virus infectivity |
| 07/31/1990 | CA1272128A1 Thrombin preparations |
| 07/30/1990 | CA2007913A1 Composition and treatment with peptide combinations |
| 07/30/1990 | CA2007525A1 Method for facilating dieting employing an ace inhibitor |
| 07/30/1990 | CA2007524A1 Method for treating addiction to a drug of abuse employing an ace inhibitor |
| 07/30/1990 | CA2007506A1 Monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides and method for production thereof |
| 07/28/1990 | WO1990008776A1 Stabilized, potent grf analogs |
| 07/28/1990 | CA2045692A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them |
| 07/28/1990 | CA2045562A1 Pharmaceutical formulations of plasminogen activator proteins |
| 07/28/1990 | CA2026776A1 Stabilized, potent grf analogs |
| 07/27/1990 | WO1990008773A1 Peptides with sulphate ester groups |
| 07/27/1990 | CA2046324A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
| 07/27/1990 | CA2045180A1 Treatment of disease associated with hiv-infections |
| 07/27/1990 | CA2026005A1 Peptides with sulphate ester groups |
| 07/27/1990 | CA2025020A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 07/27/1990 | CA2008641A1 Process for the preparation of proteins inhibiting the lymphocytotoxicity and of the complement and proteins thus obtained |
| 07/27/1990 | CA2007901A1 Urokinase precursor-lipid composite |
| 07/26/1990 | WO1990008775A1 POLYPEPTIDES HAVING A HUMAN β ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES |
| 07/26/1990 | WO1990008324A1 Cancer related haptoglobin (hpr) |
| 07/26/1990 | WO1990008198A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
| 07/26/1990 | WO1990008188A1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 07/26/1990 | WO1990008187A1 Soluble two domain cd2 protein |
| 07/26/1990 | WO1990008164A1 Somatotropin analogs |
| 07/26/1990 | WO1990008163A1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 07/26/1990 | WO1990008161A1 Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses |
| 07/26/1990 | WO1990008160A1 Growth factor receptor-like peptides without tyrosine-kinase activity |
| 07/26/1990 | WO1990008158A1 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 07/26/1990 | WO1990007937A1 Pregnancy specific proteins applications |
| 07/26/1990 | WO1990007933A1 Compositions containing thymopentin for topical treatment of skin disorders |
| 07/26/1990 | WO1990007929A1 Site specific in-vivo activation of therapeutic drugs |
| 07/26/1990 | WO1990007920A1 Osmotically dependent vesicles |
| 07/26/1990 | WO1990007863A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 07/26/1990 | WO1990007862A2 Generation and selection of novel dna-binding proteins and polypeptides |
| 07/26/1990 | WO1990007861A1 CHIMERIC IMMUNOGLOBULINS SPECIFIC FOR p55 TAC PROTEIN OF THE IL-2 RECEPTOR |
| 07/26/1990 | WO1990006949A3 Peptide derivatives |
| 07/26/1990 | DE3900770A1 Verfahren zur herstellung von pdgf-a und pdgf-aa Process for the preparation of PDGF-A and PDGF-AA |
| 07/26/1990 | CA2045126A1 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
| 07/26/1990 | CA2008534A1 Method for inhibiting tumor recurrence after surgical resection |
| 07/26/1990 | CA2008122A1 Pharmaceutical composition for diseases caused by vasoconstriction |
| 07/25/1990 | WO1990008774A1 Immunogenic compositions against gastrin peptides |
| 07/25/1990 | EP0379342A2 New FK-506 cytosolic binding protein |
| 07/25/1990 | EP0379338A2 Human insulin-like growth factor analogs and their production in yeast |
| 07/25/1990 | EP0379295A2 Anti-tryptase antibody and composition for treatment of AIDS using the same |
| 07/25/1990 | EP0378881A1 Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| 07/25/1990 | EP0378852A1 Pharmaceutical preparation for topical use |
| 07/25/1990 | EP0378827A1 Use of interleukin-4 for lowering blood glucose levels and/or effecting weight reduction |
| 07/25/1990 | EP0378676A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 07/25/1990 | EP0378671A1 Insulinomimetic and insulin receptor binding site peptides. |
| 07/25/1990 | EP0378666A1 Interleukin ii analogs |
| 07/25/1990 | EP0378655A1 Recombinomas |
| 07/25/1990 | EP0378643A1 Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection |
| 07/25/1990 | EP0378621A1 Diagnostics and therapy for rheumatoid arthritis |
| 07/25/1990 | EP0378576A1 Transduced fibroblasts and uses therefor. |
| 07/25/1990 | EP0378572A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 07/25/1990 | EP0378533A1 METHOD AND KIT FOR CONTRACEPTION WITH GnRH-ANTAGONIST AND PROGESTIN |
| 07/25/1990 | EP0213175B1 Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins |
| 07/25/1990 | CN1044103A Anti-hcg antibodies |
| 07/25/1990 | CN1044102A Peptides inhibiting maturation of t-lymphocytes and activity of macrophages, pharmaceufical compositions containing them and process for prepariny same |
| 07/25/1990 | CN1044101A Polypeptides isolated from venom of spider hololena curta |
| 07/25/1990 | CA2008334A1 Monoclonal antibodies specific for thrombin inhibitors |
| 07/24/1990 | US4943627 Prevention, treatment and detection of aids |
| 07/24/1990 | US4943562 Tetra- and pentapeptides containing the lysyl-arginyl-aspartyl sequence and their applications as medicines, particularly anti-thrombotic medicines |
| 07/24/1990 | US4943561 Antitumor |
| 07/24/1990 | US4943560 Solvent system for chronic vascular infusion of hydrophobic drugs |
| 07/24/1990 | US4943533 Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor |
| 07/24/1990 | US4943433 Plant extracts |
| 07/24/1990 | CA2025899A1 Site specific in-vivo activation of therapeutic drugs |
| 07/24/1990 | CA2008462A1 Tenascin-induced cell attachment and the tenascin receptor |
| 07/23/1990 | CA2008278A1 Rat monoclonal antibodies directed against human antigens and processes for preparation thereof |
| 07/23/1990 | CA2008264A1 Tissue plasminogen activator |
| 07/21/1990 | WO1990007932A1 Fibrinolysis |
| 07/21/1990 | CA2045574A1 Fibrinolysis |
| 07/19/1990 | DE3900688A1 Haemoglobin modified with negative charges, and its use as blood substitute |
| 07/19/1990 | CA2046925A1 Pregnancy specific proteins applications |
| 07/19/1990 | CA2045583A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
| 07/19/1990 | CA2045122A1 Osmotically dependent vesicles |
| 07/19/1990 | CA2005358A1 Somatotropin analogs |
| 07/19/1990 | CA2000355A1 Human fc-gamma receptor iii |
| 07/18/1990 | EP0378477A1 Complement inhibitory factor, its characterization and applications |
| 07/18/1990 | EP0378432A2 Novel peptides, their use to inhibit the maturation of t-lymphocytes and the activity of macrophages, and processes for their preparation |
| 07/18/1990 | EP0378418A2 Immune cell proliferation inhibitors |
| 07/18/1990 | EP0378413A2 Compositions for topical treatment of skin disorders |
| 07/18/1990 | EP0378388A1 Production of hydrogen peroxide |
| 07/18/1990 | EP0378364A2 Analogues of PF4 and fragments thereof, and pharmaceutical compositions containing them |
| 07/18/1990 | EP0378208A2 Production method for protein-containing composition |
| 07/18/1990 | EP0378171A2 The use of human BCDF for preparing a composition for treating thrombocytopenia |
| 07/18/1990 | EP0378078A1 Motilin-like polypeptide and use thereof |
| 07/18/1990 | EP0377968A2 Glutathione esters as prophylactic and therapeutic agents against cataracts |
| 07/18/1990 | EP0377855A2 Endothelial cell growth factor |
| 07/18/1990 | EP0377823A2 Use of TNF for the preparation of a medicament for the treatment of psoriasis |